{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:26:21Z","timestamp":1754108781655,"version":"3.40.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Education, Science and Technological Development of Republic of Serbia","award":["Grant number 451-03-9\/2021-14\/200110 and 175023"],"award-info":[{"award-number":["Grant number 451-03-9\/2021-14\/200110 and 175023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00520-025-09329-5","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T21:51:21Z","timestamp":1741643481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PCT-to-albumin ratio and CRP-to-albumin ratio as predictors of febrile neutropenia complications: a prospective observational trial"],"prefix":"10.1007","volume":"33","author":[{"given":"Jelena","family":"Dimitrijevi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"\u010calama\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ognjen","family":"\u0110urmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-7591","authenticated-orcid":false,"given":"Marko","family":"Stojanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"3","key":"9329_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/mco.2015.524","volume":"3","author":"DECJ Carpe\u00f1o","year":"2015","unstructured":"Carpe\u00f1o DECJ, Gasc\u00f3n-Vilaplana P, Tejerina AM, Ant\u00f3n-Torres A, L\u00f3pez-L\u00f3pez R, Barnadas-Molins A, Cruz-Hern\u00e1ndez JJ, Massuti-Sureda B, Camps-Herrero C, Aranda-Aguilar E, Laserna FJ (2015) Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study. Mol Clin Oncol 3(3):725\u2013729. https:\/\/doi.org\/10.3892\/mco.2015.524","journal-title":"Mol Clin Oncol"},{"issue":"Suppl 1","key":"9329_CR2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","volume":"39","author":"J Klastersky","year":"2004","unstructured":"Klastersky J (2004) Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 39(Suppl 1):S32\u2013S37. https:\/\/doi.org\/10.1086\/383050","journal-title":"Clin Infect Dis"},{"key":"9329_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijregi.2021.09.002","volume":"1","author":"C Sereeaphinan","year":"2021","unstructured":"Sereeaphinan C, Kanchanasuwan S, Julamanee J (2021) Mortality-associated clinical risk factors in patients with febrile neutropenia: a retrospective study. IJID Reg 1:5\u201311. https:\/\/doi.org\/10.1016\/j.ijregi.2021.09.002","journal-title":"IJID Reg"},{"issue":"3","key":"9329_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jiph.2018.12.006","volume":"12","author":"JA Al-Tawfiq","year":"2019","unstructured":"Al-Tawfiq JA, Hinedi K, Khairallah H, Saadeh B, Abbasi S, Raza NM, S, Alkhatti A, (2019) Epidemiology and source of infection in patients with febrile neutropenia: a ten-year longitudinal study. J Infect Public Health 12(3):364\u2013366. https:\/\/doi.org\/10.1016\/j.jiph.2018.12.006","journal-title":"J Infect Public Health"},{"issue":"10","key":"9329_CR5","doi-asserted-by":"publisher","first-page":"e0224299","DOI":"10.1371\/journal.pone.0224299","volume":"14","author":"RL Parodi","year":"2019","unstructured":"Parodi RL, Lagrutta M, Tortolo M, Navall E, Rodr\u00edguez MS, Sasia GF, De Candia LF, Gruvman MA, Bottasso O, Greca AA (2019) A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period. PLoS ONE 14(10):e0224299. https:\/\/doi.org\/10.1371\/journal.pone.0224299","journal-title":"PLoS ONE"},{"issue":"8","key":"9329_CR6","first-page":"S53","volume":"99","author":"B Weerasubpong","year":"2016","unstructured":"Weerasubpong B, Makruasi N, Linasmita P, Rattanamongkolgul S (2016) Factors associated with survival outcomes of febrile neutropenia in hematologic malignancy patients. J Med Assoc Thai 99(8):S53\u2013S62","journal-title":"J Med Assoc Thai"},{"issue":"10","key":"9329_CR7","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1007\/s00520-021-06154-4","volume":"29","author":"PV Bhardwaj","year":"2021","unstructured":"Bhardwaj PV, Emmich M, Knee A, Ali F, Walia R, Roychowdhury P, Clark J, Sridhar A, Lagu T, Loh KP (2021) Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study. Support Care Cancer 29(10):5905\u20135914. https:\/\/doi.org\/10.1007\/s00520-021-06154-4","journal-title":"Support Care Cancer"},{"issue":"23","key":"9329_CR8","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1002\/cam4.4355","volume":"10","author":"P Chaftari","year":"2021","unstructured":"Chaftari P, Chaftari AM, Hachem R, Yeung SJ, Dagher H, Jiang Y, Malek AE, Dailey Garnes N, Mulanovich VE, Raad I (2021) The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: a useful alternative to the multinational association for supportive care in cancer score. Cancer Med 10(23):8475\u20138482. https:\/\/doi.org\/10.1002\/cam4.4355","journal-title":"Cancer Med"},{"key":"9329_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12094-015-1442-4","volume":"18","author":"JA Virizuela","year":"2016","unstructured":"Virizuela JA, Carratal\u00e0 J, Aguado JM, Vicente D, Salavert M, Ruiz M, Ruiz I, Marco F, Lizasoain M, Jim\u00e9nez-Fonseca P, Gudiol C, Cassinello J, Carmona-Bayonas A, Aguilar M, Cruz JJ (2016) Management of infection and febrile neutropenia in patients with solid cancer. Clin Transl Oncol 18:557\u2013570. https:\/\/doi.org\/10.1007\/s12094-015-1442-4","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"9329_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/07853890.2023.2185673","volume":"55","author":"T Li","year":"2023","unstructured":"Li T, Li X, Zhu Z, Liu X, Dong G, Xu Z, Zhang M, Zhou Y, Yang J, Yang J, Fang P, Qiao X (2023) Clinical value of procalcitonin-to-albumin ratio for identifying sepsis in neonates with pneumonia. Ann Med 55(1):920\u2013925. https:\/\/doi.org\/10.1080\/07853890.2023.2185673","journal-title":"Ann Med"},{"key":"9329_CR11","doi-asserted-by":"publisher","first-page":"e11078","DOI":"10.1097\/MD.0000000000011078","volume":"97","author":"X Luo","year":"2018","unstructured":"Luo X, Yang X, Li J, Zou G, Lin Y, Qing G, Yang R, Yao W, Ye X (2018) The procalcitonin\/albumin ratio as an early diagnostic predictor in discriminating urosepsis from patients with febrile urinary tract infection. Medicine (Baltimore) 97:e11078. https:\/\/doi.org\/10.1097\/MD.0000000000011078","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"9329_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/jcm7100333","volume":"7","author":"JE Park","year":"2018","unstructured":"Park JE, Chung KS, Song JH, Kim SY, Kim EY, Jung JY, Kang YA, Park MS, Kim YS, Chang J, Leem AY (2018) The C-reactive protein\/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med 7(10):333. https:\/\/doi.org\/10.3390\/jcm7100333","journal-title":"J Clin Med"},{"key":"9329_CR13","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.2147\/JIR.S321074","volume":"14","author":"T Li","year":"2021","unstructured":"Li T, Li X, Wei Y, Dong G, Yang J, Yang J, Fang P, Qi M (2021) Predictive value of c-reactive protein-to-albumin ratio for neonatal sepsis. J Inflamm Res 14:3207\u20133215. https:\/\/doi.org\/10.2147\/JIR.S321074","journal-title":"J Inflamm Res"},{"key":"9329_CR14","doi-asserted-by":"publisher","first-page":"6621101","DOI":"10.1155\/2021\/6621101","volume":"2021","author":"Y Yu","year":"2021","unstructured":"Yu Y, Wu W, Dong Y, Li J (2021) C-reactive protein-to-albumin ratio predicts sepsis and prognosis in patients with severe burn injury. Mediator Inflamm 2021:6621101. https:\/\/doi.org\/10.1155\/2021\/6621101","journal-title":"Mediators Inflamm"},{"issue":"suppl 5","key":"9329_CR15","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J (2016) Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol 27(suppl 5):v111\u2013v118. https:\/\/doi.org\/10.1093\/annonc\/mdw325","journal-title":"Ann Oncol"},{"issue":"10","key":"9329_CR16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00520-010-0993-8","volume":"19","author":"EP Hui","year":"2011","unstructured":"Hui EP, Leung LK, Poon TC, Mo F, Chan VT, Ma AT, Poon A, Hui EK, Mak SS, Lai M, Lei KI, Ma BB, Mok TS, Yeo W, Zee BC, Chan AT (2011) Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network. Support Care Cancer 19(10):1625\u20131635. https:\/\/doi.org\/10.1007\/s00520-010-0993-8","journal-title":"Support Care Cancer"},{"issue":"8","key":"9329_CR17","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00520-013-1787-6","volume":"21","author":"S Ahn","year":"2013","unstructured":"Ahn S, Lee YS, Lim KS, Lee JL (2013) Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia. Support Care Cancer 21(8):2303\u20132308. https:\/\/doi.org\/10.1007\/s00520-013-1787-6","journal-title":"Support Care Cancer"},{"issue":"5","key":"9329_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jemermed.2020.12.010","volume":"60","author":"S Yadav","year":"2021","unstructured":"Yadav S, Mathew R, Sahu AK, Jamshed N, Mohindra R, Aggarwal P, Batra A, Halder D, Brunda RL (2021) Prognostic value of serum procalcitonin levels in patients with febrile neutropenia presenting to the emergency department. J Emerg Med 60(5):641\u2013647. https:\/\/doi.org\/10.1016\/j.jemermed.2020.12.010","journal-title":"J Emerg Med"},{"issue":"7","key":"9329_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00520-010-0925-7","volume":"19","author":"M Paesmans","year":"2011","unstructured":"Paesmans M, Klastersky J, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Ameye L (2011) Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter? Support Care Cancer 19(7):1001\u20131008. https:\/\/doi.org\/10.1007\/s00520-010-0925-7","journal-title":"Support Care Cancer"},{"key":"9329_CR20","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.12659\/MSM.892269","volume":"20","author":"M G\u00fcnalp","year":"2014","unstructured":"G\u00fcnalp M, Koyuno\u011flu M, G\u00fcrler S, Koca A, Ye\u015filkaya I, \u00d6ner E, Akka\u015f M, MetinAksu N, Demirkan A, Polat O, Elhan AH (2014) Independent factors for prediction of poor outcomes in patients with febrile neutropenia. Med Sci Monit 20:1826\u201332. https:\/\/doi.org\/10.12659\/MSM.892269","journal-title":"Med Sci Monit"},{"issue":"Suppl 1","key":"9329_CR21","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.21037\/jtd.2019.11.63","volume":"12","author":"C Gregoriano","year":"2020","unstructured":"Gregoriano C, Heilmann E, Molitor A, Schuetz P (2020) Role of procalcitonin use in the management of sepsis. J Thorac Dis 12(Suppl 1):S5\u2013S15. https:\/\/doi.org\/10.21037\/jtd.2019.11.63","journal-title":"J Thorac Dis"},{"issue":"9","key":"9329_CR22","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","volume":"57","author":"P Schuetz","year":"2019","unstructured":"Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, Gonz\u00e1lez Del Castillo J, Jensen JU, Kanizsai PL, Kwa ALH, Krueger S, Luyt CE, Oppert M, Plebani M, Shlyapnikov SA, Toccafondi G, Townsend J, Welte T, Saeed K (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med 57(9):1308\u20131318. https:\/\/doi.org\/10.1515\/cclm-2018-1181","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"9329_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1871526515666150320162950","volume":"15","author":"V Avrillon","year":"2015","unstructured":"Avrillon V, Locatelli-Sanchez M, Folliet L, Carbonnaux M, Perino E, Fossard G, Desseigne M, Freymond N, Geriniere L, Perrot E, Souquet PJ, Couraud S (2015) Lung cancer may increase serum procalcitonin level. Infect Disord Drug Targets 15(1):57\u201363. https:\/\/doi.org\/10.2174\/1871526515666150320162950","journal-title":"Infect Disord Drug Targets"},{"key":"9329_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.00147","volume":"5","author":"R Shilpakar","year":"2019","unstructured":"Shilpakar R, Paudel BD, Neupane P, Shah A, Acharya B, Dulal S, Wood LA, Shahi R, Khanal U, Poudyal BS (2019) Procalcitonin and C-reactive protein as markers of bacteremia in patients with febrile neutropenia who receive chemotherapy for acute leukemia: a prospective study from Nepal. J Glob Oncol 5:1\u20136. https:\/\/doi.org\/10.1200\/JGO.19.00147","journal-title":"J Glob Oncol"},{"key":"9329_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/B978-0-323-64068-8.00055-9","volume":"2020","author":"A Binnie","year":"2020","unstructured":"Binnie A, Lage J, Dos Santos CC (2020) How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? Evid-Based Pract Crit Care 2020:319-324.e1. https:\/\/doi.org\/10.1016\/B978-0-323-64068-8.00055-9","journal-title":"Evid-Based Pract Crit Care"},{"issue":"4","key":"9329_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5152\/TurkPediatriArs.2017.5312","volume":"52","author":"YD Kar","year":"2017","unstructured":"Kar YD, \u00d6zdemir ZC, B\u00f6r \u00d6 (2017) Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients. Turk Pediatri Ars 52(4):213\u2013220. https:\/\/doi.org\/10.5152\/TurkPediatriArs.2017.5312","journal-title":"Turk Pediatri Ars"},{"issue":"2","key":"9329_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/jcm11020312","volume":"11","author":"D Carc\u00f2","year":"2022","unstructured":"Carc\u00f2 D, Markovic U, Castorina P, Iachelli V, Pace T, Guardo P, Amato G, Galbo F, Scir\u00e8 P, Moschetti G (2022) C-reactive protein monitoring and clinical presentation of fever as predictive factors of prolonged febrile neutropenia and blood culture positivity after autologous hematopoietic stem cell transplantation-single-center real-life experience. J Clin Med 11(2):312. https:\/\/doi.org\/10.3390\/jcm11020312","journal-title":"J Clin Med"},{"issue":"1","key":"9329_CR28","first-page":"76","volume":"32","author":"A Nahar","year":"2023","unstructured":"Nahar A, Jamal CY, Refat R, Chowdhury T, Akter S, Karim A, Rahman MA, Yeamin MB, Saha BK, Hossain F, Rabbany MA (2023) Procalcitonin versus C-reactive protein as a biomarker for prediction of bacterial infection in children with febrile neutropenia in acute leukemia. Mymensingh Med J 32(1):76\u201382","journal-title":"Mymensingh Med J"},{"issue":"2","key":"9329_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.12669\/pjms.39.2.6856","volume":"39","author":"TD \u00c7ak\u0131rca","year":"2023","unstructured":"\u00c7ak\u0131rca TD, \u00c7ak\u0131rca G, Torun A, Bindal A, \u00dcst\u00fcnel M, Kaya A (2023) Comparing the predictive values of procalcitonin\/albumin ratio and other inflammatory markers in determining COVID-19 severity. Pak J Med Sci 39(2):450\u2013455. https:\/\/doi.org\/10.12669\/pjms.39.2.6856","journal-title":"Pak J Med Sci"},{"key":"9329_CR30","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.12659\/MSM.912495","volume":"25","author":"N SeringecAkkececi","year":"2019","unstructured":"SeringecAkkececi N, Yildirim Cetin G, Gogebakan H, Acipayam C (2019) The C-reactive protein\/albumin ratio and complete blood count parameters as indicators of disease activity in patients with Takayasu arteritis. Med Sci Monit 25:1401\u20131409. https:\/\/doi.org\/10.12659\/MSM.912495","journal-title":"Med Sci Monit"},{"issue":"3","key":"9329_CR31","doi-asserted-by":"publisher","first-page":"e59321","DOI":"10.1371\/journal.pone.0059321","volume":"8","author":"OT Ranzani","year":"2013","unstructured":"Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M (2013) C-reactive protein\/albumin ratio predicts 90-day mortality of septic patients. PLoS ONE 8(3):e59321. https:\/\/doi.org\/10.1371\/journal.pone.0059321","journal-title":"PLoS ONE"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09329-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:09:44Z","timestamp":1745305784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09329-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9329"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09329-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The ethical approval was obtained from the Ethical Committee of Institute for Oncology and Radiology of Serbia\/National Cancer Research Center (no. 1184\u201301) and Ethical Committee of Medical Faculty, University of Belgrade (no. 1322\/VII-15).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}